Skip to main content

Articles

Page 4 of 11

  1. Diabetes mellitus (DM) is among the most common risk factors for cardiovascular disease in the world with prevalence of more than 500 million population in 2021. Cardiac fibrosis with its complex process has b...

    Authors: Muhammad Ridwan, Herlina Dimiati, Maimun Syukri and Ronny Lesmana
    Citation: The Egyptian Heart Journal 2023 75:46
  2. Sudden cardiac death in young people is a major problem. The causes are well known; however, they may not be discovered before the episode of sudden death. A challenge for the future is identifying patients at...

    Authors: Ahmed Nabil Ali, Hend Ali Abdeltawab, Hayam Eldamanhoury and Mervat Aboulmaaty
    Citation: The Egyptian Heart Journal 2023 75:45
  3. Anti-tachycardia pacing therapy (ATP) has shown comparable efficacy to shock therapy in ventricular tachycardia (VT) termination with better quality of life. However, some ATPs may lead to VT acceleration or d...

    Authors: Sherien Samy Awad, Emmanuel Fares Azeez, Mohamed Ossama Taha, Wael Mohamed El-Naggar and Ahmed El-Damaty
    Citation: The Egyptian Heart Journal 2023 75:44
  4. The global burden of tuberculosis (TB) and cardiovascular disease (CVD) is overt, and the prevalence of this double burden disease remains steadily rising, particularly in low- and middle-income countries. Thi...

    Authors: Irawaty Djaharuddin, Muzakkir Amir and Andriany Qanitha
    Citation: The Egyptian Heart Journal 2023 75:43
  5. Treatment of newborns with univentricular hemodynamics in combination with an anomaly of pulmonary venous return has the worst correction results in modern cardiac surgical papers. According to the data obtain...

    Authors: Gorbatykh Artem, Manannikov Denis, Ivanilova Alina, Averkin Igor’, Zubarev Dmitriy, Prokhorikhin Aleksei, Soynov Ilya, Grekhov Evgeniy and Chernyavskiy Mikhail
    Citation: The Egyptian Heart Journal 2023 75:41
  6. Till the moment of this document writing, no Egyptian consensus is there to guide selection of additional antithrombotic in stable patients with established CVD. Despite use of lifestyle measures and statins, ...

    Authors: Ahmed Bendary, Bassem Zarif, Hala Mahfouz Badran, Khaled Shokry and Hamza Kabil
    Citation: The Egyptian Heart Journal 2023 75:40
  7. Oblique course of some left accessory pathways is rare An incomplete electrophysiological study may confuse us between an oblique accessory pathway or the presence of two accessory pathways. The proximity of a...

    Authors: Elibet Chávez-González, Raimundo Carmona-Puerta, Fernando Rodríguez-González, Juan Miguel Cruz-Elizundia and Cynthia Torres-Acosta
    Citation: The Egyptian Heart Journal 2023 75:37
  8. COVID-19 infections are known to cause numerous systemic complications including cardiovascular disorders. In this regard, clinicians recently noticed that patients recovering from COVID-19 infections presente...

    Authors: Sri Harsha Kanuri, Prapthi Jayesh Sirrkay and Ayse Sena Ulucay
    Citation: The Egyptian Heart Journal 2023 75:36
  9. Spontaneous Coronary Artery Dissection (SCAD) and Takotsubo Syndrome (TTS) are two different entities with several shared risk factors, but their management is different. They can co-exist in patients with che...

    Authors: Saadat Ali Saleemi, Lung En Teng and Ronald J. L. Dick
    Citation: The Egyptian Heart Journal 2023 75:35
  10. It was estimated that about 1.3 billion people were diagnosed to be hypertensive in 2015. All countries consistently show this high prevalence. Ischemic heart disease stands as the most common cause of systoli...

    Authors: Ahmed Shehata Mohamed Ismail, Mohamed Ahmed Aouf, Reda Hussein Diab and Yasser Kamel Baghdady
    Citation: The Egyptian Heart Journal 2023 75:34
  11. Coronary artery disease (CAD) is the commonest cause of death worldwide. ST-segment elevation myocardial infarction (STEMI) and its consequences can be devastating particularly at younger age for a bigger impa...

    Authors: Ahmad Samir, Mohammed Almahjori, Basem Zarif, Mai Elshinawi, Hesham Yehia, Mohamed Elhafy, Ahmed Shehata and Azza Farrag
    Citation: The Egyptian Heart Journal 2023 75:32
  12. Right ventricle infarction (RVI) is predominantly a complication of inferior wall myocardial infarction; it occurs in approximately one third of these patients. Right ventricular dysfunction in patients with i...

    Authors: Ahmed Mahmoud El Amrawy, Shaimaa Abd ElKhalek Zaghloul, Eman Mohamed El Sharkawy and Mohamed Ahmed Sobhy
    Citation: The Egyptian Heart Journal 2023 75:31
  13. Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that has a great diversity of clinical presentations and occurs mostly in young women. However, late-onset SLE does exist and seldom prese...

    Authors: I. Dewa Gde Dwi Sumajaya, I. Putu Hendri Aryadi and I. Made Eryana
    Citation: The Egyptian Heart Journal 2023 75:30
  14. Left atrium changes are implicated in atrial fibrillation (AF) substrate and are predictive of AF outcomes. Left atrial appendage (LAA) is an integral component of left atrial structure and could be affected b...

    Authors: Konstantinos A. Papathanasiou, Dimitrios A. Vrachatis, Dimitrios Kazantzis, Charalampos Kossyvakis, Sotiria G. Giotaki, Gerasimos Deftereos, Konstantinos Raisakis, Andreas Kaoukis, Dimitrios Avramides, Vaia Lambadiari, Gerasimos Siasos and Spyridon Deftereos
    Citation: The Egyptian Heart Journal 2023 75:29
  15. ST-segment elevation myocardial infarction (STEMI) is usually caused by a rupture in the atherosclerotic plaque, followed by platelet aggregation which ultimately leads to acute coronary artery occlusion. So f...

    Authors: Rozita Jalalian, Babak Bagheri, Jamshid Yazdani Charati, Shahrnaz Khalaghi, Mohammadreza Iranian and Mahsa Mohammadi
    Citation: The Egyptian Heart Journal 2023 75:28
  16. Behçet's disease BD is a rare multisystemic disease, with rare cardiac involvement. This case illustrates a rare cardiac involvement as a giant intracavitary thrombus which was the revealing form of Behçet dis...

    Authors: Anass A. Maaroufi, Sara S. Abouradi, Salah S. Hayar and Abdenacer A. Drighil
    Citation: The Egyptian Heart Journal 2023 75:27
  17. Aortic stenosis (AS) is a progressive disease, with no pharmacological treatment. The prevalence of diabetes mellitus (DM) among AS patients is higher than in the general population. DM significantly increases...

    Authors: Pranay Wal, Shruti Rathore, Namra Aziz, Yash Kumar Singh and Arpit Gupta
    Citation: The Egyptian Heart Journal 2023 75:26
  18. Elevated resting heart rate (HR) predicts poor outcomes in patients with coronary artery disease. Ivabradine has been recommended as a second-line anti-anginal agent in chronic coronary syndrome, while there a...

    Authors: Bryan Richard Sasmita, Siyuan Xie, Gang Liu, Yuansong Zhu, Suxin Luo and Bi Huang
    Citation: The Egyptian Heart Journal 2023 75:25
  19. In normal circumstances, AT secretes anti-inflammatory adipokines (AAKs) which regulates lipid metabolism, insulin sensitivity, vascular hemostasis, and angiogenesis. However, during obesity AT dysfunction occ...

    Authors: Probin Kr Roy, Johirul Islam and Hauzel Lalhlenmawia
    Citation: The Egyptian Heart Journal 2023 75:24
  20. The occurrence of major aortopulmonary collateral arteries (MAPCAs) is infrequent in patients with D-transposition of great arteries (D-TGA) with intact ventricular septum (IVS). Hemodynamically significant MA...

    Authors: Gaser Abdelmohsen, Naif AlKhushi, Abdullah Alassiri and Osman Al-Radi
    Citation: The Egyptian Heart Journal 2023 75:23
  21. Despite the spontaneous regression of many cases of coronary artery fistulas (CAFs), symptomatic patients or cases with severe shunting may require therapeutic interventions. In the present study, we aimed to ...

    Authors: Avisa Tabib, Hojjat Mortezaeian, Mohammad Mahdavi, Yasaman Khalili, Nikolaus A. Haas and Sepideh Mohammadhoseini
    Citation: The Egyptian Heart Journal 2023 75:22
  22. Cardiotoxicity is a major concern following doxorubicin (DOX) use in the treatment of malignancies. We aimed to investigate whether deferoxamine (DFO) can prevent acute cardiotoxicity in children with cancer w...

    Authors: Kosar Rahimi, Hamid Amoozgar, Soheila Zareifar, Mahdi Shahriari, Omid Reza Zekavat, Mehran Karimi, Gholamreza Fathpour, Fazl Saleh, Nader Shakibazad, Shayan Bordbar and Mohammadreza Bordbar
    Citation: The Egyptian Heart Journal 2023 75:21
  23. Low cardiorespiratory fitness is associated with poor prognosis in individuals with coronary artery disease and after coronary artery bypass grafting surgery. Thus, we comment about a meta-analysis that adds i...

    Authors: Caroline Oliveira Gois, Lino Sergio Rocha Conceição, Alana Lalucha de Andrade Guimarães and Vitor Oliveira Carvalho
    Citation: The Egyptian Heart Journal 2023 75:19

    The original article was published in The Egyptian Heart Journal 2022 74:67

  24. Authors: Ahmed Bendary, Mahmoud Hassanein, Mohamed Bendary, Ahmed Smman, Ahmed Hassanin and Mostafa Elwany
    Citation: The Egyptian Heart Journal 2023 75:18

    The original article was published in The Egyptian Heart Journal 2023 75:16

  25. Hemolysis after Patent ductus arteriosus (PDA) device closure is rare. Although in most cases, hemolysis settles on its own; however, in some cases it may not settle spontaneously and may require additional pr...

    Authors: Aamir Rashid, Ajaz Lone, Hilal Rather and Imran Hafeez
    Citation: The Egyptian Heart Journal 2023 75:17
  26. Knowledge of the frequency of precipitating factors for acute heart failure (AHF) is important (either new-onset heart failure [NOHF] or worsening heart failure [WHF]), as this can guide strategies for prevent...

    Authors: Ahmed Bendary, Mahmoud Hassanein, Mohamed Bendary, Ahmed Smman, Ahmed Hassanin and Mostafa Elwany
    Citation: The Egyptian Heart Journal 2023 75:16

    The Correction to this article has been published in The Egyptian Heart Journal 2023 75:18

  27. A double-chambered left ventricle (DCLV) is an extremely rare congenital malformation. The exact prevalence of DCLV is not known, although studies have reported prevalence of 0.04–0.42%. This abnormality is ch...

    Authors: Sheema Saadia, Aiysha Nasir and Fateh Ali Tipoo Sultan
    Citation: The Egyptian Heart Journal 2023 75:15

    The Correction to this article has been published in The Egyptian Heart Journal 2023 75:20

  28. Research on cardiovascular treatment options and prognosis in very old age groups of patients is warranted. In our study, we evaluated and followed up on clinical conditions on admission and comorbidities of p...

    Authors: Bedrettin Boyraz, Tezcan Peker, Alkame Akgümüş and Ahmet Balun
    Citation: The Egyptian Heart Journal 2023 75:14
  29. Cardiovascular disease (CVD) is the most common cause of death in patients with renal diseases. Cardiac arrhythmia and sudden cardiac death are particularly important, and the burden is higher in patients on h...

    Authors: Hesham Yehia, Ghada Youssef, Mona Gamil, Mahmoud Elsaeed and Khaled M. Sadek
    Citation: The Egyptian Heart Journal 2023 75:13
  30. Low-level laser therapy (LLLT) is a promising noninvasive physiotherapeutic approach that has been demonstrated to improve cardiac performance. This study aimed to assess the impact of low-level laser therapy ...

    Authors: Mahmoud Abdulbasser Sayed, Rania M. El-Sherif, Amira Ismail, Ahmed Essam Abou Warda, Amany R. Mohamed and Ahmed A. El-Sherif
    Citation: The Egyptian Heart Journal 2023 75:12
  31. Trastuzumab and trastuzumab emtansine are specific antibody and antibody–drug conjugates used in the treatment of human epidermal growth factor receptor 2 (HER2) positive metastatic breast cancer. The aim of t...

    Authors: Rea Levicki, Martina Lovrić Benčić, Irena Ivanac Vranešić, Lada Bradić, Marta Begovac, Juraj Jug and Natalija Dedić Plavetić
    Citation: The Egyptian Heart Journal 2023 75:11
  32. Bronchopulmonary dysplasia (BPD) is still a major concern in preterm infants and adequate screening methods for secondary right ventricle (RV) failure are needed. Early detection could be aided by taking measu...

    Authors: Marcos Clavero-Adell, Daniel Palanca-Arias, Marta López-Ramón, Lorenzo Jimenez-Montañés, Itziar Serrano-Viñuales, Segundo Rite-Gracia and Ariadna Ayerza-Casas
    Citation: The Egyptian Heart Journal 2023 75:10
  33. Tetralogy of Fallot is a severe type of congenital heart disease (CHD) and one of the leading indirect causes of mortality & morbidity among women with CHD. We came across a rare case of an uncorrected Tetralo...

    Authors: Surekha Thakur, Neha Rawat, Bharti Sharma, Pooja Sikka, Neeti Dogra, Neelam Aggarwal, Vanita Suri, Rajesh Vijayvergiya and Atit A. Gawalkar
    Citation: The Egyptian Heart Journal 2023 75:9
  34. Despite the recent progress made in drug-eluting stents (DESs), in-stent restenosis (ISR) is still a common complication of percutaneous coronary interventions. This retrospective study from a single center ai...

    Authors: Mohamed Aymen Ben Abdessalem, Anis Ghariani, Ahmed Fekih Romdhane, Fatma Ichrmad, Zied Ben Ameur, Wassim Saoudi, Hatem Bouraoui, Abdallah Mahdhaoui and Samia Ernez Hajri
    Citation: The Egyptian Heart Journal 2023 75:8
  35. Sepsis is a leading cause of death and it is characterized not only by profound vasoplegia but also by myocardial dysfunction. Critical care echocardiography is the preferred modality for the initial assessmen...

    Authors: Luigi La Via, Federica Merola, Giovanni Schembari, Calogero Liotta and Filippo Sanfilippo
    Citation: The Egyptian Heart Journal 2023 75:7
  36. Infective endocarditis remains a serious condition. Left ventricular pseudoaneurysm may complicate the clinical course of infective endocarditis or occur postoperatively.

    Authors: Chighaly El Hadj Sidi, Varha Isselmou, Mohamed Feissal Mohamed Ahmed, El Hadj Abdelaziz Diop, Taleb Ekhyar Argueina, Haimouda Mady and Khaled Boye
    Citation: The Egyptian Heart Journal 2023 75:6
  37. For patients with ST-elevation myocardial infarction (STEMI), early reperfusion with primary percutaneous coronary intervention (PPCI) or thrombolytic treatment is essential to prevent major adverse cardiac ev...

    Authors: Amr Kamal, Amr Zaki, Ahmed Abdelaaty and Moustafa Madkour
    Citation: The Egyptian Heart Journal 2023 75:5
  38. Mavacamten, an allosteric myosin inhibitor, is considered to be a promising drug for the treatment of hypertrophic cardiomyopathy (HCM). This meta-analysis aimed to explore the safety and efficacy of mavacamte...

    Authors: Mehrdad Rabiee Rad, Ghazal Ghasempour Dabaghi and Danial Habibi
    Citation: The Egyptian Heart Journal 2023 75:4
  39. Adults with congenital heart disease (ACHD) are a group with an increased risk of thromboembolic complications and arrhythmias. Vitamin K antagonists are the most commonly used thromboprophylaxis therapy in th...

    Authors: Daniel Samarai, Nazim Isma, Sandra Lindstedt and Joanna Hlebowicz
    Citation: The Egyptian Heart Journal 2023 75:3
  40. We aimed to evaluate the prognostic effects of stroke risk scores (SRS), SYNTAX score (SX score), and PRECISE-DAPT score on mortality in patients with non-ST-segment elevation myocardial infarction (NSTEMI). T...

    Authors: Gökhan Alıcı, Ömer Genç, Örsan Deniz Urgun, Tayfur Erdoğdu, Abdullah Yıldırım, Alaa Quisi and İbrahim Halil Kurt
    Citation: The Egyptian Heart Journal 2023 75:2
  41. The most prevalent illness among the elderly is coronary artery disease (CAD), and most of this population present with multi-vessel CAD which constitutes a common management difficulty among elderly people. T...

    Authors: Amr Kamal, Abdel Megeid Kandil, Mohamed Sadaka and Basem Ramadan
    Citation: The Egyptian Heart Journal 2022 74:86
  42. Telerehabilitation enables patients to communicate with physicians through the Internet and may be utilized to evaluate patients’ conditions and offer treatment plans. This method became necessary as a result ...

    Authors: Hady Atef, Marwa Gaber and Bassem Zarif
    Citation: The Egyptian Heart Journal 2022 74:85
  43. It is known that cardiovascular events (CVE) occur more often in winter than in summer. However, dependence of myocardial infarction (MI) risk of on various meteorological factors is still not fully understood...

    Authors: Nataliya V. Kuzmenko, Vitaliy A. Tsyrlin, Mikhail G. Pliss and Mikhail M. Galagudza
    Citation: The Egyptian Heart Journal 2022 74:84

Affiliated with

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 1.4
    5-year Journal Impact Factor: 1.3
    Source Normalized Impact per Paper (SNIP): 0.603
    SCImago Journal Rank (SJR): 0.377

    Speed 2023
    Submission to first editorial decision (median days): 18
    Submission to acceptance (median days): 116

    Usage 2023
    Downloads: 423,260
    Altmetric mentions: 306

Egyptian Knowledge Bank (EKB) Journals

New Content Item (1)

Visit our collection of Egyptian journals.